A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment?
Introduction: In Europe and beyond, the rising costs of healthcare and limited healthcare resources have resulted in the implementation of health technology assessment (HTA) to inform health policy and reimbursement decision-making. European legislation has provided a harmonized route for the regula...
Main Authors: | Nicola Allen, Lawrence Liberti, Stuart R. Walker, Sam Salek |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00384/full |
Similar Items
-
The role of HTA agencies in Poland and in the world
by: Aneta Katarzyna Mela
Published: (2020-07-01) -
Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?
by: Virginia Ronco, et al.
Published: (2021-03-01) -
SOCIOECONOMIC CHARACTERISTICS OF COUNTRIES BASED ON THE PRESENCE OF HTA AGENCY
by: Svetlin Georgiev, et al.
Published: (2017-08-01) -
HTA CORE MODEL
by: R. I. Yagudina, et al.
Published: (2015-03-01) -
Factors Influencing Delays in Patient Access to New Medicines in Canada: A Retrospective Study of Reimbursement Processes in Public Drug Plans
by: Sam Salek, et al.
Published: (2019-03-01)